Eric Arnaud Diendéré
Biographic Data
| ID | 8937256 |
|---|---|
| NAME | Eric Arnaud Diendéré |
| GIVEN NAMES | Eric Arnaud |
| FAMILY NAME | Diendéré |
| SIGNATURE | DIENDÉRÉ E A |
| AFFILIATIONS | Université Joseph Ki-Zerbo |
| ORCID | 0000-0002-0369-1535 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2015 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Characteristics, management and factors associated with poor outcomes in Covid-19 patients in Burkina Faso
Objectives: To assess treatment and identify predictive factors of worsening in COVID-19 patients. Methods: This study was ambispective (both prospective and retrospective) and part of a multidisciplinary, multicenter project designed to generate epidemiological, sociological and anthropological data about the COVID-19 epidemic in Burkina Faso. Medical records of patients admitted for COVID-19 at the hospitals of Ouagadougou and Bobo-Dioulasso fr…
Incidence and Predictors of Imported Cases of Covid-19 in Burkina Faso
BACKGROUND: To limit the spread of COVID-19 due to imported cases, Burkina Faso has set up quarantine measures for arriving passengers. We aimed to determine the incidence and predictors of imported cases of COVID-19 in Burkina Faso. METHODS: 2) platform. Cox regression was used to identify predictors of imported cases of COVID-19. RESULTS: Among 6,332 travelers who arrived in the study period, 173 imported cases (2.7%) were recorded. The inciden…
Clinical outcomes and mortality associated factors in patients infected with HIV receiving a presumptive anti-tuberculosis treatment in a tertiary level hospital in Burkina Faso
INTRODUCTION: Tuberculosis is the leading cause of death among people living with HIV/AIDS (PLHIV) in sub-Saharan Africa. In PLHIV, Smear-Negative Pulmonary Tuberculosis (SNPTB) and Extrapulmonary Tuberculosis (EPTB) are predominant. Presumptive anti-tuberculosis (anti-TB) treatment is often delayed leading to a high mortality rate. OBJECTIVES: To investigate the clinical outcomes of presumptive anti-TB treatment in HIV patients suspected of havi…
No prominent works on this page.
Clinical outcomes and mortality associated factors in patients infected with HIV receiving a presumptive anti-tuberculosis treatment in a tertiary level hospital in Burkina Faso
INTRODUCTION: Tuberculosis is the leading cause of death among people living with HIV/AIDS (PLHIV) in sub-Saharan Africa. In PLHIV, Smear-Negative Pulmonary Tuberculosis (SNPTB) and Extrapulmonary Tuberculosis (EPTB) are predominant. Presumptive anti-tuberculosis (anti-TB) treatment is often delayed leading to a high mortality rate. OBJECTIVES: To investigate the clinical outcomes of presumptive anti-TB treatment in HIV patients suspected of havi…
Incidence and Predictors of Imported Cases of Covid-19 in Burkina Faso
BACKGROUND: To limit the spread of COVID-19 due to imported cases, Burkina Faso has set up quarantine measures for arriving passengers. We aimed to determine the incidence and predictors of imported cases of COVID-19 in Burkina Faso. METHODS: 2) platform. Cox regression was used to identify predictors of imported cases of COVID-19. RESULTS: Among 6,332 travelers who arrived in the study period, 173 imported cases (2.7%) were recorded. The inciden…
Characteristics, management and factors associated with poor outcomes in Covid-19 patients in Burkina Faso
Objectives: To assess treatment and identify predictive factors of worsening in COVID-19 patients. Methods: This study was ambispective (both prospective and retrospective) and part of a multidisciplinary, multicenter project designed to generate epidemiological, sociological and anthropological data about the COVID-19 epidemic in Burkina Faso. Medical records of patients admitted for COVID-19 at the hospitals of Ouagadougou and Bobo-Dioulasso fr…
Internal Medicine (3 works) · Medicine (3 works) · Disease (2 works) · Geography (2 works) · Pathology (2 works) · SARS-CoV-2 and COVID-19 Research (2 works) · 2019-20 coronavirus outbreak (1 work) · Asymptomatic (1 work) · Confidence interval (1 work) · COVID-19 Clinical Research Studies (1 work)